종양학과
무수혈 조혈모세포이식
Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support. (새로운 창 열기)
Source: Br J Haematol 2013;161(5):738-40.
Indexed: PubMed 23480574
DOI: 10.1111/bjh.12284
Autologous stem-cell transplantation can be performed safely without the use of blood-product support. (새로운 창 열기)
Source: J Clin Oncol 2004;22(20):4087-94.
Indexed: PubMed 15353543
DOI: 10.1200/JCO.2004.01.144
Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients. (새로운 창 열기)
Source: Bone Marrow Transplant 2020;55(6):1059-67.
Indexed: PubMed 31898692
DOI: 10.1038/s41409-019-0777-9
The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products. (새로운 창 열기)
Source: Bone Marrow Transplant 2006;37(3):325-7.
Indexed: PubMed 16314850
DOI: 10.1038/sj.bmt.1705223
Hematopoietic stem cell transplantation without the use of blood components by the patient's choice: experience of 2 Brazilian centers. (새로운 창 열기)
Source: Biol Blood Marrow Transplant 2020;26(3):458-62.
Indexed: PubMed 31669397
DOI: 10.1016/j.bbmt.2019.10.018
Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - literature review and local experience. (새로운 창 열기)
Source: Transfus Apher Sci 2017;56(3):317-21.
Indexed: PubMed 28642120
DOI: 10.1016/j.transci.2017.05.022
Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (새로운 창 열기)
Source: J Clin Oncol 2015;33(15):1674-9.
Indexed: PubMed 25870085
DOI: 10.1200/JCO.2014.57.9912
Myeloablative chemotherapy and autologous stem cell transplantation without the use of blood products. (새로운 창 열기)
Source: Biol Blood Marrow Transplant 2005;11(2 Suppl 1):66-7.
DOI: 10.1016/j.bbmt.2004.12.199
http://www.bbmt.org/article/S1083-8791(04)00851-1/fulltext (새로운 창 열기)
Safety and survival outcomes for bloodless transplantation in patients with myeloma. (새로운 창 열기)
Source: Cancer 2019;125(2):185-93.
Indexed: PubMed 30480777
DOI: 10.1002/cncr.31677
Bloodless tandem autologous transplant in Jehovah's Witness patients. (새로운 창 열기)
Source: Bone Marrow Transplant 2018. [Epub ahead of print]
Indexed: PubMed 29795417
DOI: 10.1038/s41409-018-0132-6
Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (새로운 창 열기)
Source: Bone Marrow Transplant 2003;32(4):433-6.
Indexed: PubMed 12900781
DOI: 10.1038/sj.bmt.1704179
Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (새로운 창 열기)
Source: Bone Marrow Transplant 2005;36(8):715-20.
Indexed: PubMed 16113672
DOI: 10.1038/sj.bmt.1705126
SCT in Jehovah's Witnesses: the bloodless transplant. (새로운 창 열기)
Source: Bone Marrow Transplant 2008;41(10):837-44.
Indexed: PubMed 18246110
DOI: 10.1038/bmt.2008.5